Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.93B
Enterprise Value3.61B
P/E Ratio46.6
PEG Ratio5.01
Price/Sales Ratio4.38
Price/Book Ratio2.48
Enterprise/Revenue4.73
Enterprise/EBITDA27.99

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue1.5B
Revenue/Share5.04
Gross Profit526.71M
EBITDA307.19M
Net Income102.23M
Diluted EPS0.47

Balance Sheet

Total Cash642.9M
Total Cash/Share1.93
Total Debt1.06B
Total Debt/Equity0.36
Current Ratio1.43
Book Value Per Share9.06

Price History

52-Week Change37.44
52-Week High50.28
52-Week Low13.55
Moving Average 50 Days27.12
Moving Average 200 Days26.95

Statistics

Average Volume50.81M
Shares Outstanding339.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.16
Trailing Annual Dividend Yield0.71
Payout Ratio0.12
Last Split Factor7:5
Last Split DateJuly 09, 2026
AD